<?xml version="1.0" encoding="UTF-8"?>
<p>A limitation of this study is that we did not have access to specimens from virally unsuppressed treated subjects, and we are therefore unable to rigorously estimate FRR in this group, which may be substantial in many surveillance settings [
 <xref rid="pone.0220345.ref026" ref-type="bibr">26</xref>]. We urge survey planners and analysts to conduct sensitivity analyses with respect to FRR when utilising either assay in cross-sectional incidence estimation.
</p>
